Seeking Alpha

Seeking Alpha Portfolio App for iPad

2,220 people get BDX articles and Market Currents by email alert.

Get email alerts on BDX »

BDX

Becton, Dickinson and Company

5/25/2013, 12:01 PM ET

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Tuesday, May 21, 12:32 PM Becton, Dickinson and Company (BDX) declares $0.495/share quarterly dividend, in line with previous. Forward yield 1.96%. For shareholders of record June 7. Payable June 28. Ex-div date June 5. (PR) Comment! [Dividends]
Thursday, May 2, 12:07 PM Becton Dickinson (BDX +2.9%) trades up after a solid FQ2 earnings beat this morning. Net earnings fell 5.3% Y/Y however as a new medical-device tax overshadowed better revenue. Medical unit revenue rose 4% to $1.06B. Revenue at the diagnostics unit increased 4.6%, and bio-sciences revenue was up 0.6%. The medical-device maker also raised its FY13 earnings by $0.03 to a range of $5.72 to $5.75 a share and backed its revenue growth projection of 3.5% - 4%. Comment! [Healthcare, Earnings, On the Move]
Thursday, May 2, 6:02 AM Becton Dickinson (BDX): Q1 EPS of $1.44 beats by $0.08. Revenue of $2.0B (+3.7% Y/Y) beats by $0.01B. (PR) Comment! [Earnings, Breaking News, Healthcare]
Thursday, May 2, 12:05 AM Notable earnings before Thursday’s open: ABMD, ACOR, ACT, AEE, ANR, ANSS, ARG, ARQL, ATK, AYR, BDBD, BDX, BEAM, BGCP, BZH, CAH, CEVA, CHD, CI, CME, CNP, CPN, CTRX, DIN, DNR, EL, ELNK, FIG, FLY, FNP, FWLT, GEL, GG, GIL, GM, GNRC, GOLD, HAR, HK, HSH, INCY, INGR, IP, IRDM, IT, ITT, K, LF, LQDT, LXP, MDC, MFC, MGI, MGM, MMC, MMP, MWW, NIHD, NNN, NUS, OCN, OGE, OXF, OZM, PCG, PPL, PWR, PXP, RGLD, RNO, SBH, SFY, SHPG, SNI, SPR, SRE, STRA, TEVA, VMC, VRX, WNR, WPX, WWE, XEL Comment! [Earnings]
Wednesday, May 1, 5:30 PM Notable earnings before Thursday’s open: ABMD, ACOR, ACT, AEE, ANR, ANSS, ARG, ARQL, ATK, AYR, BDBD, BDX, BEAM, BGCP, BZH, CAH, CEVA, CHD, CI, CME, CNP, CPN, CTRX, DIN, DNR, EL, ELNK, FIG, FLY, FNP, FWLT, GEL, GG, GIL, GM, GNRC, GOLD, HAR, HK, HSH, INCY, INGR, IP, IRDM, IT, ITT, K, LF, LQDT, LXP, MDC, MFC, MGI, MGM, MMC, MMP, MWW, NIHD, NNN, NUS, OCN, OGE, OXF, OZM, PCG, PPL, PWR, PXP, RGLD, RNO, SBH, SFY, SHPG, SNI, SPR, SRE, STRA, TEVA, VMC, VRX, WNR, WPX, WWE, XEL Comment! [Earnings]
Friday, April 12, 3:37 PM BD Medical, a segment of Becton, Dickinson (BDX -0.3%) says its BD UltraSafe Plus Passive Needle Guard has received FDA 510(k) clearance as an anti-needlestick safety device. The device provides needlestick safety with enhanced with ergonomic features designed to be easier to use for healthcare providers and patients. Comment! [Healthcare]
Wednesday, March 13, 8:39 AM Becton, Dickinson (BDX) appoints Ellen Strahlman to the newly created position of Chief Medical Officer and Senior VP of R&D. Strahlman comes from GlaxoSmithKline, where she was CMO. Most recently, she worked in the Office of the CEO as Senior Medical Adviser and Global Head of Neglected Tropical Diseases. (PR) Comment!
Thursday, February 28, 10:25 AM A new study published in the journal Clinical Infectious Diseases found that Becton Dickinson's (BDX +0.1%) BD Bactec Plus Aerobic medium, a test that detects bacteria in blood cultures, had faster detection time and increased overall bacterial recovery from blood cultures where antimicrobials had been administered to septic patients within 48 hours before collection, as compared to another commonly used aerobic blood culture medium. Comment! [Healthcare]
Tuesday, February 5, 12:33 PM Becton Dickinson (BDX +2.8%) moves up after its FQ1 easily tops estimates. Net profit more than doubled on revenue growth across all segments, while margins widened to 52.9% from 50.8%. Sales in its U.S. markets grew by 3% Y/Y, and 4.3% internationally. Sales in its medical unit, the largest by revenue, rose 3.5%. For the current year, The company bumps up the bottom end of revenue guidance, now expecting revenue growth starting at 4% versus its prior view of 3.5%, and an EPS of between $5.69 and $5.72, up from its earlier view of $5.58 to $5.64. Comment! [Healthcare, Earnings, On the Move]
Tuesday, February 5, 6:03 AM Becton Dickinson (BDX): FQ1 EPS of $1.35 beats by $0.11. Revenue of $1.90B (+3.7% Y/Y) beats by $0.04B. (PR) Comment! [Earnings, Breaking News, Healthcare]
Tuesday, February 5, 12:05 AM Notable earnings before Tuesday’s open: ACI, ACM, ADM, ADP, AGCO, AGN, ALLT, ARMH, ATK, BDX, BP, CAH, CHD, CSC, DLPH, DO, EL, EMR, ETN, K, MMP, NGPC, NRGY, NYX, OHI, SE, SEP, SIRI, TE, TM, UBS, UDR, VSH Comment! [Earnings]
Monday, February 4, 5:30 PM Notable earnings before Tuesday’s open: ACI, ACM, ADM, ADP, AGCO, AGN, ALLT, ARMH, ATK, BDX, BP, CAH, CHD, CSC, DLPH, DO, EL, EMR, ETN, K, MMP, NGPC, NRGY, NYX, OHI, SE, SEP, SIRI, TE, TM, UBS, UDR, VSH Comment! [Earnings]
Tuesday, January 29, 1:46 PM Becton, Dickinson and Co. (BDX) declares $0.495/share quarterly dividend, in line with previous. Forward yield 2.35%. For shareholders of record Mar. 08. Payable Mar. 29. Ex-div date Mar. 06. (PR) Comment! [Dividends]
Tuesday, November 20, 2012, 9:04 AM Becton, Dickinson and Company (BDX) declares $0.49/share quarterly dividend, 10.0% increase from prior dividend of $0.45. Forward yield 2.61%. For shareholders of record Dec. 10. Payable Dec. 31. Ex-div Dec. 6. (PR) 1 Comment [Dividends]
Wednesday, November 7, 2012, 10:07 AM More on Becton Dickinson (BDX -3.8%) FQ4: net profit -3.6% to $289M, with earnings hurt by weak revenue at its biosciences and medical ops, pension settlement charges, and forex fluctuations. U.S. sales +1.2%, international -2.6%, but +7.1% excluding currency impact. Gross margin falls to 50.9% from 51.2%. Expects FY revenue growth of 2%-3% and EPS from continuing ops of $5.58-$5.64 vs consensus of +3% and $5.80. Comment! [Earnings, On the Move, Healthcare]
Wednesday, November 7, 2012, 6:10 AM Becton Dickinson (BDX): FQ4 EPS of $1.42 beats by $0.02. Revenue of $1.97B (-1.1% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]